đź“‹ FDA Reference
eyeyon hioxirilcon d soft hydrophillc contactlensesfor daily wear hyper-cl hioxirilcon d therapeuticsoft hydrophillc contact lensesfor daily wear
Eyeyon Medical
Summary: The Eyeyon Hioxirilcon D Soft Hydrophilic Contact Lenses are designed for daily wear and therapeutic use. They are primarily used by ophthalmologists for patients requiring vision correction or therapeutic treatment of ocular conditions.
FDA Clearance Information
Pathway
510K
Number
K153305 ↗
Decision Date
April 8, 2016
Product Code
LPL
Device Class
Class 2
Evidence
419 studies
The Eyeyon Hioxirilcon D Soft Hydrophilic Contact Lenses were cleared through the FDA 510(k) pathway on April 8, 2016. Manufactured by Eyeyon Medical, these lenses are classified as Class 2 medical devices.
What It Is
These are soft hydrophilic contact lenses made from Hioxirilcon D, designed for daily wear. They are used to correct refractive errors or provide therapeutic benefits for various ocular conditions. The lenses work by covering the cornea and providing a smooth refractive surface, which can also protect the eye and aid in healing.
Clinical Applications
These contact lenses are commonly used in ophthalmology for patients with refractive errors such as myopia, hyperopia, or astigmatism. They are also used therapeutically for conditions like corneal abrasions or keratitis, providing a protective barrier and promoting healing. Suitable for use in outpatient settings and specialized eye clinics, they cater to a wide range of patients, including those with specific therapeutic needs.
Indications for Use
The FDA indications suggest these lenses are for daily wear to correct vision or provide therapeutic benefits. They are suitable for patients with refractive errors or those needing ocular surface protection and healing.
Practical Considerations
These lenses are available in various sizes to fit different corneal shapes. They should be used with compatible cleaning solutions and stored properly to maintain hygiene. Clinicians should ensure proper fitting and educate patients on correct usage techniques.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is Eyeyon Hioxirilcon D Soft Contact Lenses used for?
They are used for correcting refractive errors and providing therapeutic benefits for ocular conditions.
What specialties typically use this device?
Ophthalmologists and optometrists typically use these lenses in clinical practice.
What are the FDA-cleared indications?
The lenses are indicated for daily wear to correct vision or provide therapeutic benefits for ocular conditions.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.